- Home
- APLS vs CVCO Comparison
APLS vs CVCO Comparison
Compare APLS & CVCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | APLS | CVCO |
|---|---|---|
| Founded | 2009 | 1965 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 4.5B |
| IPO Year | 2015 | 1994 |
Fundamental Metrics
Financial Performance| Metric | APLS | CVCO |
|---|---|---|
| Price | $40.86 | $519.88 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 21 | 1 |
| Target Price | $32.71 | ★ $550.00 |
| AVG Volume (30 Days) | ★ 8.0M | 140.7K |
| Earning Date | 05-06-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.50 | 12.74 |
| EPS | 0.20 | ★ 18.55 |
| Revenue | $1,003,782,000.00 | ★ $2,142,713,000.00 |
| Revenue This Year | N/A | $14.66 |
| Revenue Next Year | $18.19 | $7.70 |
| P/E Ratio | $204.20 | ★ $28.20 |
| Revenue Growth | 28.46 | ★ 31.68 |
| 52 Week Low | $16.10 | $393.53 |
| 52 Week High | $40.87 | $713.01 |
Technical Indicators
Market Signals| Indicator | APLS | CVCO |
|---|---|---|
| Relative Strength Index (RSI) | 87.65 | 55.20 |
| Support Level | $18.53 | $488.88 |
| Resistance Level | N/A | $604.08 |
| Average True Range (ATR) | 0.27 | 17.39 |
| MACD | 1.31 | 8.95 |
| Stochastic Oscillator | 99.94 | 86.91 |
Price Performance
Historical ComparisonAbout APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade. Currently it has two marketed drugs that target C3, the central protein in the complement cascade: SYFOVRE (pegcetacoplan injection) and EMPAVELI (pegcetacoplan).
About CVCO Cavco Industries Inc. When Issued
Cavco Industries Inc designs and produces factory-built homes under the Cavco Homes, Fleetwood Homes, and Palm Harbor Homes brands. It also produces modular homes, park model homes, and vacation cabins, as well as commercial structures, among others. The company operates principally in two segments: Factory-built housing, which includes wholesale and retail systems-built housing operations, and the Financial services segment, which includes manufactured housing consumer finance and insurance. Cavco receives a majority of its revenue from the Factory-built housing segment.